CSF2 and cancer: In addition, the potential application of SINV-GM-CSF in treating various cancers is promising for future studies, as the SINV can reach the entire body by intraperitoneal or intravenous injection, and this hematogenous characteristic makes it advantageous for the treatment of metastases and some microscopic lesions.